4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0000905148-25-003069
Chief Accounting Officer sold 1,809 shares at an average $11.61 ($21,009)
From the SEC's structured data for this filing
Trades in this filing
Grant-Huerta Yanina · Chief Accounting Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-18 | Sale : show line 1 in the form | −55 | $11.61 | $638 | 37,012 | D |
| 2025-08-18 | Sale : show line 2 in the form | −86 | $11.61 | $999 | 36,926 | D |
| 2025-08-18 | Sale : show line 3 in the form | −1,668 | $11.61 | $19,372 | 35,258 | D |
| Open-market sales · 1,809 sh · avg $11.61 · $21,009 | ||||||
Loading xslF345X05/form4.xml…